VitaminA, E, and D deficiencies in tunisian very low birth weight neonates: prevalence and risk factors

Samira Fares1, Mohamed Marouane Sethom1, Chahnez Khouaja-Mokrani2

  • 1UR05/08-08, Department of Biochemistry, Rabta Hospital and Faculty of Medicine of Tunis, El Manar University, 1007 Tunis, Tunisia.

Insights

Very low birth weight (VLBW) neonates in Tunisia have alarmingly high rates of vitamin A, E, and D deficiencies. These deficiencies are linked to maternal health conditions like pre-eclampsia, necessitating improved prenatal care and infant supplementation.

Area of Science:

  • Neonatology
  • Nutritional Science
  • Public Health

Background:

  • Preterm neonates, particularly very low birth weight (VLBW) infants, face significant risks of vitamin deficiencies.
  • These deficiencies can lead to increased morbidity and mortality in vulnerable newborns.

Purpose of the Study:

  • To determine the prevalence of vitamin A, E, and D deficiencies in Tunisian VLBW neonates.
  • To identify risk factors associated with these deficiencies in this population.

Main Methods:

  • A study involving 607 VLBW neonates and 300 term neonates.
  • Plasma vitamin A and E levels measured using high-performance liquid chromatography.
  • Plasma vitamin D levels measured using radioimmunoassay.

Main Results:

  • VLBW neonates exhibited significantly higher prevalence of vitamin A (75.9%), E (71.3%), and D (65.2%) deficiencies compared to term neonates.
  • Deficiency rates correlated with lower gestational age and birth weight.
  • Vitamin E deficiency linked to pre-eclampsia and gestational diabetes; Vitamin D deficiency linked to twin pregnancy and pre-eclampsia.

Conclusions:

  • Vitamin A, E, and D deficiencies are highly prevalent in Tunisian VLBW neonates.
  • Maternal pre-eclampsia is a significant associated factor for both vitamin E and D deficiencies.
  • Enhanced maternal nutritional support and high-dose vitamin supplementation for VLBW infants are crucial in Tunisia.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
558
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
98